## FICO: Fair Isaac Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -2.0% below STRENGTH zone (3.0-6.0%); PEG 2.38 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($1646.87)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. WINTON GROUP Ltd Makes New Investment in Equifax, Inc. $EFX**
- Source: MarketBeat | 20251208T130808 | Somewhat-Bullish | Relevance: 72%
-  WINTON GROUP Ltd recently acquired a new stake of 17,623 shares in Equifax for approximately $4.57 million, contributing to institutional ownership exceeding 96%. Equifax outperformed Q3 estimates with $2.04 EPS and $1.54 billion revenue, while setting optimistic guidance for Q4 and FY2025. Despite recent insider selling, the company announced a quarterly dividend of $0.50 per share.

**2. Amundi Buys 23,161 Shares of Equifax, Inc. $EFX**
- Source: MarketBeat | 20251209T080808 | Somewhat-Bullish | Relevance: 64%
- Amundi has increased its stake in Equifax, Inc. (NYSE:EFX) by 11.2%, acquiring an additional 23,161 shares, bringing its total holdings to 230,283 shares valued at approximately $60.4 million. Several other institutional investors also adjusted their positions in the credit services provider during the second quarter. Meanwhile, company insiders, including CEO Mark W. Begor and EVP Jamil Farshchi, sold a significant number of shares, while Wall Street analysts provided a "Moderate Buy" consensus rating with a target price of $276.40.

**3. Invesco Ltd. Reduces Stock Position in Equifax, Inc. $EFX**
- Source: MarketBeat | 20251206T112647 | Somewhat-Bullish | Relevance: 60%
-  Invesco Ltd. reduced its stake in Equifax, Inc. by 10.4% in the second quarter, selling 187,288 shares and ending with 1,621,234 shares worth $420,499,000. Other institutional investors also adjusted their positions in Equifax. The article details Equifax's stock performance, recent earnings, dividend announcement, and analyst ratings, noting an average rating of "Moderate Buy" with a consensus price target of $277.13.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 12 ($0.00M) |
| Sells | 4 ($0.66M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.0% (+2.4%)
- Blackrock Inc.: 9.8% (-8.4%)
- State Street Corpora: 4.5% (-1.2%)
- Capital World Invest: 3.4% (+874.4%)
- Valley Forge Capital: 3.2% (0.0%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.38 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 36%, ROA 33%, margin 33%). Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $42.3B |
| Beta | 1.29 |
| 52W Range | $1300.00 - $2361.83 |
| Short Interest | 6.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.38 |
| Forward P/E | 34.5 |
| Current P/E | 43.0 |
| YoY Growth | 24.6% |
| EPS Direction | RISING |

### Technicals

MRS_10 stable at -2.0% (minimal 5-day change). Below STRENGTH zone by 5.0pp (needs >3.0% for momentum thesis). Underperforming sector by 3.2pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.03x) but short-term weakness (below SMA20). MACD histogram bearish (-4.44), momentum weakening. RSI neutral at 53.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.04% (CS: 35) | Weak |
| RSI_14 | 52.7 | Neutral |
| MACD Histogram | -4.44 | Bearish |
| vs SMA20 | 0.996x | Below |
| vs SMA50 | 1.036x | Above |
| vs SMA200 | 1.029x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $1760.45
- **Stop Loss:** $1646.87 (6.5% risk)
- **Target:** $1874.03 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 10
- **Position Value:** $17,604.50
- **Portfolio %:** 17.60%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

### Earnings

**Next:** 2026-02-03 (Est: $7.11)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $7.36 | $7.74 | +5.2% |
| 2025Q2 | $7.70 | $8.57 | +11.3% |
| 2025Q1 | $7.44 | $7.81 | +4.9% |
| 2024Q4 | $6.08 | $5.79 | -4.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*